Bbjs Financial Advisors, LLC Bristol Myers Squibb CO Transaction History
Bbjs Financial Advisors, LLC
- $280 Billion
- Q3 2024
A detailed history of Bbjs Financial Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bbjs Financial Advisors, LLC holds 137 shares of BMY stock, worth $8,174. This represents 0.0% of its overall portfolio holdings.
Number of Shares
137
Previous 310
55.81%
Holding current value
$8,174
Previous $12.9 Million
45.02%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BMY
# of Institutions
2,568Shares Held
1.46BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$11.3 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.47 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.54 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.65 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.64 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $127B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...